Dewpoint Therapeutics
Translating condensate biology into medicine.
Boston, United States · Founded 2018 · $346.1M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2018
- Business Model
- B2B
- Website
- dewpointx.com
- Total Funding
- $346.1M
- Last Round
- $59.1M Series DSep 2025
- Rounds
- 4
About
Dewpoint Therapeutics is the leading biotech company applying the biology of biomolecular condensates to drug discovery and development. Using its AI/ML-enabled ERSA platform, Dewpoint is building a pipeline of first-in-class condensate modulators (c-mods) targeting oncology, neurodegenerative, cardiopulmonary, and metabolic diseases, with strategic collaborations with Bayer, Novo Nordisk, and Mitsubishi Tanabe Pharma.
Summary
Dewpoint Therapeutics is a Life Sciences company based in Boston, United States, founded in 2018. It has raised $346.1M in total across 4 rounds, most recently a $59.1M Series D round in Sep 2025. Investors include Polaris Partners, ARCH Venture Partners and SoftBank.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Polaris Partners
3 rounds
ARCH Venture Partners
2 rounds
.png)
SoftBank
1 round
Leaps by Bayer
3 rounds
Samsara BioCapital
3 rounds
EcoR1 Capital
3 rounds
Maverick Ventures
2 rounds
General Catalyst
1 round
Mubadala Capital
1 round
3E Bioventures Capital
1 round
Mirae Asset
1 round
NS Investment
1 round
Bellco Capital
1 round
Innovation Endeavors
1 round
6 Dimensions Capital
1 round
Alexandria Venture Investments
1 round
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...